Israel Englander Cabaletta Bio, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 855,330 shares of CABA stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

855,330

Previous 168,899 406.42%

Holding current value

$1.14 Million

Previous $234,000 455.56%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.04 - $2.48 $713,888 - $1.7 Million	686,431 Added 406.42%	855,330 $1.3 Million
Q1 2025 May 15, 2025	SELL	$1.39 - $2.74 $476,372 - $939,036	-342,714 Reduced 66.99%	168,899 $234,000
Q4 2024 Feb 14, 2025	SELL	$1.87 - $4.91 $2.09 Million - $5.49 Million	-1,117,300 Reduced 68.59%	511,613 $1.13 Million
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $3.67 Million - $7.67 Million	930,596 Added 133.26%	1,628,913 $7.69 Million
Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $1.73 Million - $4.5 Million	238,950 Added 52.02%	698,317 $5.22 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $7.71 Million - $11.7 Million	459,367 New	459,367 $7.84 Million
Q2 2023 Aug 14, 2023	SELL	$7.65 - $13.95 $1.54 Million - $2.8 Million	-201,049 Reduced 35.14%	371,070 $4.79 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $1.56 Million - $2.79 Million	220,994 Added 62.94%	572,119 $4.73 Million
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $77,166 - $1.12 Million	120,572 Added 52.3%	351,125 $3.25 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $2.05 $4,840 - $15,750	-7,683 Reduced 3.22%	230,553 $150,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $121,537 - $259,034	-122,765 Reduced 34.01%	238,236 $253,000
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $367,691 - $857,946	218,864 Added 153.98%	361,001 $733,000
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $68,923 - $300,310	20,513 Added 16.87%	142,137 $539,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $6.08 Million - $10.9 Million	-868,706 Reduced 87.72%	121,624 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $823,802 - $1.34 Million	114,417 Added 13.06%	990,330 $8.52 Million
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $2.81 Million - $3.93 Million	270,668 Added 44.72%	875,913 $9.72 Million
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $33,501 - $53,957	3,415 Added 0.57%	605,245 $7.55 Million
Q3 2020 Nov 16, 2020	SELL	$9.71 - $14.41 $292,018 - $433,366	-30,074 Reduced 4.76%	601,830 $6.52 Million
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $1.53 Million - $2.7 Million	239,089 Added 60.87%	631,904 $7.04 Million
Q1 2020 May 14, 2020	BUY	$6.0 - $18.67 $917,190 - $2.85 Million	152,865 Added 63.71%	392,815 $2.87 Million
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $1.89 Million - $4.25 Million	239,950 New	239,950 $3.35 Million

Others Institutions Holding CABA

# of Institutions

Shares Held

77M

Call Options Held

406K

Put Options Held

90.9K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $38.6M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account